Linder E, Edgington T S
Clin Exp Immunol. 1973 Feb;13(2):279-92.
Anti-erythrocyte autoantibodies of two distinct antigenic specificities can be recovered from immunoglobulin-coated NZB erythrocytes. These autoantibodies react with either exposed (X) or hidden (HB) antigenic determinants on murine red cells and both types can be neutralized by mouse plasma. Antibody neutralization by plasma is dependent on two distinct plasma activities which appear to be soluble analogues of the erythrocyte surface autoantigens X and HB. The soluble erythrocyte antigens SEA-X and SEA-HB can be separated by molecular exclusion chromatography, with approximate sizes of 2 × 10 for SEA–X and ≥ 5 × 10 for SEA-HB. The presence of these soluble erythrocyte autoantigens in the plasmas of `autoimmune' NZB mice has to be considered in relation to the immunologic homeostasis of these autoantibody responses and pathogenesis of both the autoimmune haemolytic anaemia and the autologous immune complex disease of these mice. Individual anti-erythrocyte autoantibodies of both anti-X and anti-HB types exhibit discrete and individually distinctive differences in affinity for autoantigen and also in respect to antigenic determinant specificity. These results suggest that factors which control the genetic selection of these responses in an inbred strain do not prescribe a single specific B lymphoid cell clone; but rather it appears that a number of different autoimmunocompetent B lymphocyte clones with differing affinity and determinant specificity for given autoantigen molecules may be dere-pressed by other events in the recruitment of the autoantibody responses.
可从免疫球蛋白包被的新西兰黑鼠(NZB)红细胞中分离出具有两种不同抗原特异性的抗红细胞自身抗体。这些自身抗体可与小鼠红细胞上暴露的(X)或隐蔽的(HB)抗原决定簇发生反应,并且两种类型的抗体均可被小鼠血浆中和。血浆对抗体的中和作用取决于两种不同的血浆活性,这两种活性似乎是红细胞表面自身抗原X和HB的可溶性类似物。可溶性红细胞抗原SEA-X和SEA-HB可通过分子排阻色谱法分离,SEA-X的大小约为2×10,SEA-HB的大小≥5×10。必须结合这些自身抗体反应的免疫稳态以及这些小鼠自身免疫性溶血性贫血和自身免疫复合物疾病的发病机制,来考虑“自身免疫性”NZB小鼠血浆中这些可溶性红细胞自身抗原的存在情况。抗X型和抗HB型的单个抗红细胞自身抗体在对自身抗原的亲和力以及抗原决定簇特异性方面均表现出离散且各自独特的差异。这些结果表明,在近交系中控制这些反应的基因选择的因素并非规定单一特定的B淋巴细胞克隆;相反,似乎在自身抗体反应的募集过程中,其他事件可能会使许多对给定自身抗原分子具有不同亲和力和决定簇特异性的不同自身免疫活性B淋巴细胞克隆解除抑制。